miércoles, 2 de octubre de 2019

CDER SBIA: Pharmaceutical Quality Symposium Oct 16-17, 2019



Oct. 16-17, 2019 | College Park, MD or Online | Free
About
FDA will discuss the latest developments in pharmaceutical quality and provide case studies that illustrate the most effective ways to address quality issues and interact with the agency.

In this era of globalization, engaging stakeholders is essential to furthering the overall commitment to pharmaceutical quality. FDA’s goal for this event is to share information and emphasize the critical role quality plays in assuring the safety and efficacy of pharmaceutical products.  

We look forward to discussing this commitment to quality with you at this symposium.
Topics Covered

  • Manufacturing and the Quality Assessment of Applications
  • Quality Beyond Application Approval
  • Emerging Technologies in Pharmaceutical Manufacturing and Design
  • Happenings in Biologics: Biosimilars and Transition Biological Products
Keynote FDA Speakers

Patrizia Cavazzoni, MD
Deputy Center Director for Operations
Center for Drug Evaluation and Research (CDER) | FDA
 
Michael Kopcha, PhD, RPh
Director
Office of Pharmaceutical Quality (OPQ) | CDER | FDA

No hay comentarios: